Skip to main content

Table 2 Regression analyses

From: Impact of pharmacy worker training and deployment on access to essential medicines for children under five in Malawi: a cluster quasi-experimental evaluation

 

Any antimalarial

AL

Antibiotic

ORS

Model 1

Model 2

Model 3

Model 1

Model 2

Model 3

Model 1

Model 2

Model 3

Model 1

Model 2

Model 3

Unadj

Adj

Unadj

Adj

Unadj

Adj

Unadj

Adj

Unadj

Adj

Unadj

Adj

Unadj

Adj

Unadj

Adj

Unadj

Adj

Unadj

Adj

Unadj

Adj

Unadj

Adj

Constant

−0.285**

−0.624**

−0.285**

−0.625**

−0.285**

−0.611**

−0.587***

−1.097***

−0.587***

−1.100***

−0.587***

−1.088***

0.869***

0.951**

0.869***

0.947**

0.869***

0.949**

−0.613***

−0.975**

−0.613***

−0.929**

−0.613***

−0.925**

 

(0.116)

(0.255)

(0.116)

(0.254)

(0.116)

(0.253)

(0.092)

(0.247)

(0.092)

(0.244)

(0.092)

(0.244)

(0.160)

(0.445)

(0.160)

(0.446)

(0.160)

(0.446)

(0.175)

(0.417)

(0.175)

(0.424)

(0.175)

(0.424)

Intervention

−0.222

−0.188

−0.222

−0.187

−0.222

−0.188

−0.010

0.026

−0.010

0.029

−0.010

0.028

−0.199

−0.513**

−0.199

−0.513**

−0.199

−0.513**

0.208

0.121

0.208

0.116

0.208

0.113

 

(0.180)

(0.169)

(0.180)

(0.169)

(0.180)

(0.169)

(0.170)

(0.163)

(0.170)

(0.163)

(0.170)

(0.163)

(0.234)

(0.245)

(0.234)

(0.245)

(0.234)

(0.245)

(0.261)

(0.268)

(0.261)

(0.268)

(0.261)

(0.269)

Post Intervention

0.045

0.019

    

0.252*

0.230*

    

−0.420**

−0.453**

    

0.315

0.339

    
 

(0.156)

(0.156)

    

(0.133)

(0.138)

    

(0.211)

(0.213)

    

(0.219)

(0.230)

    

Intervention* Post-Intervention

0.590**

0.565**

0.588**

0.560**

  

0.374*

0.335

0.364

0.323

  

−0.123

−0.078

−0.133

−0.087

  

−0.339

−0.297

−0.298

−0.251

  
 

(0.234)

(0.224)

(0.235)

(0.225)

  

(0.222)

(0.216)

(0.223)

(0.217)

  

(0.306)

(0.307)

(0.308)

(0.308)

  

(0.298)

(0.302)

(0.305)

(0.309)

  

year 2015

  

0.026

−0.014

−0.085

−0.123

  

0.172

0.132

0.082

0.042

  

−0.329

−0.362

−0.379

−0.395

  

0.543**

0.582**

0.392

0.422*

   

(0.176)

(0.177)

(0.206)

(0.209)

  

(0.146)

(0.152)

(0.166)

(0.173)

  

(0.249)

(0.246)

(0.270)

(0.274)

  

(0.228)

(0.236)

(0.243)

(0.253)

year 2016

  

0.062

0.051

0.169

0.157

  

0.328**

0.324**

0.413**

0.410**

  

−0.488**

−0.524**

−0.451*

−0.500**

  

0.046

0.051

0.227

0.251

   

(0.164)

(0.163)

(0.176)

(0.175)

  

(0.151)

(0.155)

(0.170)

(0.174)

  

(0.221)

(0.227)

(0.233)

(0.233)

  

(0.244)

(0.254)

(0.253)

(0.267)

year 2015* Intervention

    

0.794***

0.762***

    

0.529**

0.488*

    

−0.054

−0.036

    

−0.002

0.070

     

(0.282)

(0.281)

    

(0.251)

(0.252)

    

(0.361)

(0.375)

    

(0.350)

(0.353)

year 2016* Intervention

    

0.409

0.384

    

0.223

0.179

    

−0.197

−0.130

    

−0.612*

−0.597*

     

(0.264)

(0.251)

    

(0.262)

(0.253)

    

(0.374)

(0.359)

    

(0.332)

(0.341)

N

2873

2873

2873

2873

2873

2873

2873

2873

2873

2873

2873

2873

1036

1036

1036

1036

1036

1036

1552

1552

1552

1552

1552

1552

Log-Likelihood

−1963

−1922

−1963

−1921

−1961

−1919

−1939

−1893

−1938

−1891

−1937

−1889

−679

−653

−678

−652

−678

−652

−1041

−1022

−1033

−1014

−1031

−1010

AIC

3935

3871

3937

3873

3935

3871

3887

3813

3886

3811

3885

3810

1365

1333

1366

1335

1368

1337

2090

2072

2077

2057

2073

2053

  1. AL Artemether Lumefantrine, ORS Oral Rehydration Salts, Unadj unadjusted models, Adj models adjusted for child’s age and sex, care giver’s age and sex, level of education and marital status, and the household socioeconomic status (wealth index)
  2. * p < 0.1; ** p < 0.05; *** p < 0.01